Healthcare & Medical Equipment Suppliers Sector Financials, Performance and Ratios
-
Sector Score
31.9 /100
Rank 24 out of 27 Sectors -
Advance/Decline
86/124
-
No. of Companies210
-
Avg. Market Cap8,935
-
Price to Earning Ratio29.83
-
Price to Earning Growth Ratio3.65
-
Price to Book Ratio6.24
-
Return on Equity39.14
-
Return on Capital Employed-
-
Return on Assets5.88
-
Dividend yield 1 year %0.28 %
-
Net Profit Growth Annual YoY %-10.02 %
-
Net Profit Growth Qtr YoY %8.16 %
-
Net Profit Growth Qtr QoQ %-0.44 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Healthcare & Medical Equipment Suppliers Sector Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Healthcare & Medical Equipment Suppliers Peer comparison
Compare all stocks in Healthcare & Medical Equipment Suppliers industry listed on stock exchanges
| Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Agilent Tech |
|
32,674.5
|
115.6
|
L
 -2.6%
H
113.3
118.1
|
L
 0.1%
H
111.8
120.3
|
L
 1.5%
H
110.3
124.9
|
L
 -10.8%
H
109.9
130.0
|
L
 7.5%
H
106.6
160.3
|
L
 -13.3%
H
96.4
160.3
|
L
 -13.7%
H
96.4
179.6
|
L
 179.1%
H
41.3
179.6
|
| Amerisource Bergen Corp |
|
-
|
261.1
|
L
 2.1%
H
254
266.4
|
L
 -15.2%
H
244.8
310.4
|
L
 -18.6%
H
244.8
328.0
|
L
 -27.3%
H
244.8
376.9
|
L
 -10.0%
H
244.8
377.5
|
L
 55.4%
H
163.4
377.5
|
L
 116.0%
H
111.3
377.5
|
L
 241.2%
H
68.4
377.5
|
| Abbott |
|
146,869.7
|
84.3
|
L
 -3.1%
H
84.1
87.3
|
L
 -7.1%
H
84.1
91
|
L
 -17.2%
H
84.1
103.8
|
L
 -23.9%
H
84.1
116.8
|
L
 -37.1%
H
84.1
139.1
|
L
 -24.2%
H
84.1
141.2
|
L
 -29.1%
H
84.1
142.6
|
L
 122.1%
H
36.8
142.6
|
| Alcon Inc - Registered Shares |
|
30,510.5
|
62.6
|
L
 -2.1%
H
62.4
64.8
|
L
 -16.4%
H
62.4
75.4
|
L
 -16.2%
H
62.4
82.4
|
L
 -20.6%
H
62.4
87.6
|
L
 -34.9%
H
62.4
97.1
|
L
 -15.1%
H
62.4
101.1
|
L
 -10.8%
H
55.2
101.1
|
L
H
39.4
101.1
|
| Artivion Inc |
|
1,232.3
|
25.4
|
L
 -28.3%
H
19.2
27.3
|
L
 -29.1%
H
19.2
36.8
|
L
 -27.9%
H
19.2
39.7
|
L
 -35.8%
H
19.2
41
|
L
 -10.5%
H
19.2
48.3
|
L
 67.3%
H
12.2
48.3
|
L
 -17.1%
H
9.6
48.3
|
L
 107.4%
H
9.6
48.3
|
| Avanos Medical Inc |
|
1,161.3
|
24.8
|
L
 0.1%
H
24.8
24.8
|
L
 0.7%
H
24.6
24.8
|
L
 81.2%
H
13.8
24.8
|
L
 70.0%
H
12.8
24.8
|
L
 97.1%
H
9.3
24.8
|
L
 3.5%
H
9.3
26.6
|
L
 -39.7%
H
9.3
45.4
|
L
 -15.4%
H
9.3
73.0
|
| Baxter International |
|
9,291.3
|
18.0
|
L
 2.9%
H
17.3
18
|
L
 2.3%
H
16.5
18
|
L
 8.2%
H
16.2
19.2
|
L
 -17.2%
H
15.7
22.4
|
L
 -41.4%
H
15.7
32.7
|
L
 -60.9%
H
15.7
50.2
|
L
 -79.2%
H
15.7
89.7
|
L
 -60.1%
H
15.7
95.2
|
| Becton, Dickinson and Co. |
|
41,936.0
|
149.4
|
L
 -2.5%
H
146.5
155.3
|
L
 0.3%
H
143
155.3
|
L
 -3.6%
H
143
160.0
|
L
 -28.9%
H
143
211.5
|
L
 -10.6%
H
143
213.1
|
L
 -41.1%
H
143
287.3
|
L
 -36.0%
H
143
287.3
|
L
 -7.1%
H
143
287.3
|
| Butterfly Network Inc (Class A) |
|
1,088.4
|
4.2
|
L
 -1.9%
H
4.1
4.3
|
L
 -13.2%
H
4.1
5.4
|
L
 2.7%
H
4.0
5.7
|
L
 23.1%
H
2.8
5.7
|
L
 90.8%
H
1.3
5.7
|
L
 93.5%
H
0.7
5.7
|
L
 -65.8%
H
0.7
15.7
|
L
H
0.7
29.1
|
| Bio-Rad Laboratories Inc (Class A) |
|
6,806.0
|
254.3
|
L
 -1.2%
H
251.3
258.8
|
L
 -9.2%
H
242.3
264.3
|
L
 -8.5%
H
242.3
312.9
|
L
 -15.7%
H
242.3
312.9
|
L
 9.4%
H
211.4
343.1
|
L
 -34.0%
H
211.4
431.8
|
L
 -58.2%
H
211.4
832.7
|
L
 79.6%
H
135.9
832.7
|
| Bausch + Lomb Corp |
|
5,768.8
|
16.2
|
L
 1.7%
H
15.7
16.3
|
L
 1.8%
H
15.7
16.4
|
L
 1.6%
H
15.3
17.1
|
L
 -4.8%
H
15.1
18.9
|
L
 41.9%
H
11.0
18.9
|
L
 -7.5%
H
10.5
22.0
|
L
H
10.5
22.0
|
L
H
10.5
22.0
|
| Boston Scientific |
|
80,159.1
|
53.9
|
L
 -4.7%
H
53.6
56.6
|
L
 -6.4%
H
53.6
58.2
|
L
 -12.8%
H
53.6
66.9
|
L
 -29.3%
H
53.6
76.9
|
L
 -48.5%
H
53.6
109.5
|
L
 4.6%
H
48.4
109.5
|
L
 25.0%
H
35.0
109.5
|
L
 144.8%
H
19.7
109.5
|
| Cardinal Health |
|
43,011.9
|
183.7
|
L
 -0.9%
H
182.9
190.2
|
L
 -4.8%
H
182.9
200.4
|
L
 -13.7%
H
182.9
217.8
|
L
 -18.9%
H
182.9
233.6
|
L
 19.7%
H
137.8
233.6
|
L
 120.7%
H
80.9
233.6
|
L
 215.8%
H
45.9
233.6
|
L
 139.0%
H
39.1
233.6
|
| Conmed Corp |
|
1,106.8
|
36.8
|
L
 -3.5%
H
36.6
38.7
|
L
 0.3%
H
35.1
38.7
|
L
 6.4%
H
35.1
40.6
|
L
 -11.5%
H
33.2
47.1
|
L
 -34.4%
H
33.2
61.1
|
L
 -70.7%
H
33.2
138.5
|
L
 -74.4%
H
33.2
159.1
|
L
 -14.4%
H
33.2
159.1
|
| Cooper Companies |
|
11,706.9
|
60
|
L
 -1.8%
H
59.7
61.5
|
L
 -4.6%
H
59.7
62.9
|
L
 -13.9%
H
59.7
72.6
|
L
 -26.9%
H
59.7
84.6
|
L
 -26.2%
H
59.7
89.8
|
L
 -37.8%
H
59.7
112.4
|
L
 -40.6%
H
59.7
115.9
|
L
 56.5%
H
38.1
115.9
|
| Danaher |
|
121,142.0
|
171.2
|
L
 -2.6%
H
170.7
175.5
|
L
 -4.4%
H
170.7
179.9
|
L
 -10.4%
H
170.7
200.5
|
L
 -21.0%
H
170.7
220.9
|
L
 -11.4%
H
170.7
242.8
|
L
 -29.4%
H
170.7
281.7
|
L
 -33.8%
H
170.7
334.0
|
L
 132.6%
H
73.2
334.0
|
| Edwards Lifesciences |
|
46,312.8
|
80.0
|
L
 -3.4%
H
79.2
83.0
|
L
 -4.2%
H
79.2
85.1
|
L
 -1.1%
H
77.1
85.1
|
L
 1.6%
H
74.7
87.3
|
L
 6.6%
H
72.3
87.9
|
L
 -9.9%
H
58.9
96.1
|
L
 -13.2%
H
58.9
131.7
|
L
 126.8%
H
27.0
131.7
|
| Glaukos Corp |
|
7,842.2
|
133.5
|
L
 -0.5%
H
130.0
135.3
|
L
 -7.1%
H
130.0
146.8
|
L
 16.0%
H
113
146.8
|
L
 18.7%
H
95.9
146.8
|
L
 51.3%
H
73.2
146.8
|
L
 145.0%
H
54.4
163.7
|
L
 60.8%
H
33.3
163.7
|
L
 479.8%
H
23.1
163.7
|
| Globus Medical Inc (Class A) |
|
10,575.1
|
78.0
|
L
 -8.4%
H
76.5
85.6
|
L
 -13.6%
H
76.5
92.4
|
L
 -13.4%
H
76.5
97.4
|
L
 -11.2%
H
76.5
97.9
|
L
 9.0%
H
51.8
101.4
|
L
 33.4%
H
43.4
101.4
|
L
 6.3%
H
43.4
101.4
|
L
 240.5%
H
19.3
101.4
|
| Haemonetics Corp |
|
2,561.5
|
55.1
|
L
 1.4%
H
51
56.1
|
L
 -8.3%
H
51
60.7
|
L
 -7.5%
H
51
62.8
|
L
 -7.1%
H
51
66.1
|
L
 -14.2%
H
47.3
87.3
|
L
 -33.0%
H
47.3
98.0
|
L
 -9.7%
H
43.5
98.0
|
L
 98.3%
H
26.0
142.1
|
| Herbalife Nutrition Ltd |
|
1,485.4
|
14.3
|
L
 -1.2%
H
14.0
14.7
|
L
 -13.8%
H
14.0
17.0
|
L
 2.7%
H
14.0
17.5
|
L
 -15.8%
H
13.6
20.4
|
L
 110.8%
H
6.6
20.4
|
L
 1.7%
H
5.0
20.4
|
L
 -71.5%
H
5.0
55.8
|
L
 -55.0%
H
5.0
61.8
|
| Inspire Medical Systems Inc |
|
1,275.3
|
44.3
|
L
 -2.9%
H
44.0
45.7
|
L
 -21.2%
H
44.0
57.9
|
L
 -18.7%
H
44.0
59.0
|
L
 -32.6%
H
44.0
86
|
L
 -71.7%
H
44.0
161.9
|
L
 -84.0%
H
44.0
330
|
L
 -77.3%
H
44.0
330
|
L
H
22.5
330
|
| Integer Holdings Corp |
|
2,992.1
|
88.1
|
L
 0.2%
H
86.2
89.3
|
L
 -0.4%
H
83.2
90
|
L
 3.5%
H
77.1
91.1
|
L
 1.9%
H
77.1
100.1
|
L
 -25.9%
H
62
123.8
|
L
 7.1%
H
62
146.4
|
L
 -7.3%
H
50.1
146.4
|
L
 171.9%
H
18.1
146.4
|
| McKesson |
|
90,161.8
|
736.1
|
L
 -2.5%
H
726.0
772.4
|
L
 -9.7%
H
726.0
821
|
L
 -14.1%
H
726.0
879.1
|
L
 -22.4%
H
726.0
999
|
L
 1.9%
H
637
999
|
L
 101.2%
H
364.4
999
|
L
 272.5%
H
184.4
999
|
L
 335.9%
H
106.1
999
|
| Medtronic |
|
97,767.8
|
76.2
|
L
 -2.3%
H
75.9
78.3
|
L
 -6.0%
H
75.9
81.2
|
L
 -11.9%
H
75.9
88.8
|
L
 -26%
H
75.9
103.6
|
L
 -8.4%
H
75.9
106.3
|
L
 -15.4%
H
68.9
106.3
|
L
 -39.9%
H
68.9
135.9
|
L
 -4.5%
H
68.9
135.9
|
| Mettler-Toledo International |
|
22,768.6
|
1,124.5
|
L
 -14.8%
H
1110.8
1228.9
|
L
 -11.9%
H
1110.8
1347.0
|
L
 -11.5%
H
1110.8
1365.8
|
L
 -18.1%
H
1110.8
1422.4
|
L
 3.7%
H
1077.2
1525.2
|
L
 -21.1%
H
928.5
1546.9
|
L
 -12.1%
H
928.5
1714.8
|
L
 214.7%
H
343.6
1714.8
|
| Envista Holdings Corp |
|
3,972.9
|
24.2
|
L
 -0.2%
H
24.1
25.0
|
L
 -6.6%
H
24.1
29.5
|
L
 -4.2%
H
24.1
29.5
|
L
 -16.7%
H
24.1
30.4
|
L
 43.9%
H
16.4
30.4
|
L
 -31.4%
H
14.2
36.1
|
L
 -46.7%
H
14.2
52.0
|
L
H
10.1
52.0
|
| Owens & Minor Inc |
|
273.6
|
3.6
|
L
 -4.3%
H
3.6
3.8
|
L
 -3.5%
H
3.6
3.9
|
L
 40.9%
H
2.5
4.0
|
L
 49.8%
H
1.9
4.0
|
L
 -53.9%
H
1.8
9.6
|
L
 -80.8%
H
1.8
28.4
|
L
 -89.6%
H
1.8
49.2
|
L
 -89.9%
H
1.8
49.2
|
| Penumbra Inc |
|
12,655.7
|
322.2
|
L
 -0.8%
H
321.8
324.9
|
L
 -1.3%
H
321.8
327.4
|
L
 -2.3%
H
321.8
335.2
|
L
 -5.5%
H
321.8
344.5
|
L
 11.4%
H
221.3
362.4
|
L
 3.9%
H
148
362.4
|
L
 18.7%
H
114.9
362.4
|
L
 489.0%
H
45.9
362.4
|
| Koninklijke Philips N.V. (ADR) |
|
25,892.3
|
27.2
|
L
 0.2%
H
27.1
27.5
|
L
 3.3%
H
26.1
27.8
|
L
 0.7%
H
25.1
30.0
|
L
 -7.6%
H
25.1
33.4
|
L
 13.9%
H
22.0
33.4
|
L
 28.7%
H
17.8
33.4
|
L
 -53.5%
H
11.8
57.7
|
L
 4.6%
H
11.8
61.2
|
| Qiagen NV |
|
6,808.7
|
33.0
|
L
 -1.4%
H
32.9
33.4
|
L
 -4.5%
H
32.9
34.8
|
L
 -17.7%
H
32.9
42.3
|
L
 -35.2%
H
32.9
52.2
|
L
 -26.4%
H
32.9
57.8
|
L
 -35.6%
H
32.9
57.8
|
L
 -37.9%
H
32.9
64.7
|
L
 31.1%
H
23.1
65.9
|
| ResMed |
|
29,991.9
|
206.8
|
L
 -0.1%
H
203.9
208.0
|
L
 -3.3%
H
198.6
213.5
|
L
 -8.5%
H
198.6
234.9
|
L
 -23.9%
H
198.6
277.7
|
L
 -15.5%
H
198.6
293.8
|
L
 -10.7%
H
132.2
293.8
|
L
 5.9%
H
132.2
301.3
|
L
 266.1%
H
56.3
301.3
|
| Steris PLC |
|
20,345.7
|
207.5
|
L
 -2.9%
H
207.0
214.3
|
L
 -4.4%
H
195.1
218.3
|
L
 -5.4%
H
195.1
227.9
|
L
 -17.7%
H
195.1
255.7
|
L
 -7.8%
H
195.1
269.4
|
L
 9.7%
H
185.2
269.4
|
L
 -1.9%
H
159.2
269.4
|
L
 190.9%
H
63.3
269.4
|
| Stevanato Grp Spa |
|
4,976.9
|
18.2
|
L
 1.1%
H
18.0
18.8
|
L
 7.2%
H
17.0
19.1
|
L
 33.7%
H
13.4
19.1
|
L
 17.6%
H
12.9
19.1
|
L
 -16.4%
H
12.9
28
|
L
 -32.1%
H
12.9
36.3
|
L
H
12.9
36.3
|
L
H
12.9
36.3
|
| Stryker |
|
109,306.5
|
285.5
|
L
 -3.0%
H
285.0
294.9
|
L
 -9.4%
H
285.0
313.3
|
L
 -14.0%
H
285.0
352.8
|
L
 -20.3%
H
285.0
389.3
|
L
 -25.7%
H
285.0
404.9
|
L
 0.3%
H
250.0
406.2
|
L
 12.0%
H
188.8
406.2
|
L
 156.7%
H
106.5
406.2
|
| Smith & Nephew PLC (ADR) |
|
12,783.4
|
30.0
|
L
 -0.3%
H
29.6
30.3
|
L
 -3.2%
H
29.6
31.6
|
L
 -5.6%
H
29.6
34.7
|
L
 -13.7%
H
29.6
37.1
|
L
 5.7%
H
28.0
38.8
|
L
 -6.5%
H
21.5
38.8
|
L
 -31.9%
H
21.5
44.5
|
L
 -10.4%
H
21.5
52.3
|
| Teleflex Incorporated |
|
5,890.0
|
133.1
|
L
 1.1%
H
130.9
135.7
|
L
 7.4%
H
118.5
136.3
|
L
 15.2%
H
117.5
139.7
|
L
 22.7%
H
102.6
139.7
|
L
 9.0%
H
100.2
139.7
|
L
 -48.4%
H
100.2
263.0
|
L
 -67.7%
H
100.2
428.4
|
L
 -17.4%
H
100.2
449.4
|
| Thermo Fisher |
|
172,804.0
|
465
|
L
 -2.0%
H
456.4
473.5
|
L
 -2.9%
H
456.4
481.8
|
L
 -5.0%
H
455.6
538.4
|
L
 -14.3%
H
455.6
551.0
|
L
 14.0%
H
385.5
644.0
|
L
 -14.9%
H
385.5
644.0
|
L
 -0.7%
H
385.5
672.3
|
L
 216.4%
H
139.1
672.3
|
| Waters |
|
34,861.5
|
355.1
|
L
 1.3%
H
339.2
357.0
|
L
 14.8%
H
298.9
357.0
|
L
 15.5%
H
287.2
357.0
|
L
 -6.9%
H
282.8
357.0
|
L
 2.8%
H
275.1
414.2
|
L
 19.7%
H
231.9
423.6
|
L
 12.9%
H
231.9
428.2
|
L
 167.4%
H
131.4
428.2
|
| West Pharma Services |
|
23,025.5
|
325.9
|
L
 1.2%
H
316.1
328.4
|
L
 9.5%
H
294.3
328.4
|
L
 25.7%
H
254.6
328.4
|
L
 30.9%
H
227.5
328.4
|
L
 52.9%
H
202.8
328.4
|
L
 -11.5%
H
187.4
415.7
|
L
 -2.3%
H
187.4
475.4
|
L
 363.0%
H
70.0
475.4
|
| Zimmer Biomet Holdings |
|
15,927.8
|
82.3
|
L
 -1.3%
H
82.0
84.0
|
L
 -0.1%
H
82.0
84.5
|
L
 -9.9%
H
79.8
97.8
|
L
 -8.4%
H
79.8
101.5
|
L
 -12.5%
H
79.8
108.3
|
L
 -40.3%
H
79.8
147.5
|
L
 -49.3%
H
79.8
163.0
|
L
 -24.2%
H
70.0
169.7
|
| BioRad Laboratories Inc |
|
7,356.7
|
255.5
|
L
 -2.2%
H
255.5
255.5
|
L
 -14.7%
H
255.5
261.4
|
L
 -7.8%
H
255.5
299.5
|
L
 -13.4%
H
255.5
299.5
|
L
 9.0%
H
247.1
321.1
|
L
 -23.1%
H
225.3
373.4
|
L
 -23.1%
H
225.3
373.4
|
L
 -23.1%
H
225.3
373.4
|
| Haleon PLC (ADR) |
|
40,434.4
|
9.1
|
L
 -2.0%
H
9.1
9.2
|
L
 -1.4%
H
9.1
9.4
|
L
 -7.8%
H
9.1
10.1
|
L
 -17.0%
H
9.1
11.3
|
L
 -15.3%
H
8.7
11.4
|
L
 3.6%
H
7.7
11.4
|
L
H
5.6
11.4
|
L
H
5.6
11.4
|
| Revvity |
|
11,292.1
|
101
|
L
 2.2%
H
94.6
102.2
|
L
 16.6%
H
85.0
102.2
|
L
 15.1%
H
81.2
102.2
|
L
 -0.6%
H
81.2
106.5
|
L
 10.3%
H
81.2
118.3
|
L
 -22.2%
H
79.5
132.0
|
L
 -28.4%
H
79.5
203.2
|
L
 86.2%
H
45.4
203.2
|
| Aethlon Medical Inc |
|
3.5
|
2.3
|
L
 -2.2%
H
2.3
2.5
|
L
 0.9%
H
2.2
2.5
|
L
 7.7%
H
2.1
2.5
|
L
 0.9%
H
1.4
2.5
|
L
 -92.5%
H
1.4
35.2
|
L
 -99.2%
H
1.4
400
|
L
 -99.8%
H
1.4
9992
|
L
 -100.0%
H
1.4
109078.8
|
| Ainos Inc |
|
12.4
|
1.7
|
L
 -2.3%
H
1.7
1.8
|
L
 -2.3%
H
1.7
1.8
|
L
 14.9%
H
1.5
2.0
|
L
 -11.0%
H
1.3
2.0
|
L
 -37.0%
H
1.3
4.5
|
L
 -90.9%
H
1.3
30.5
|
L
 -99.4%
H
1.3
1781.3
|
L
 347.4%
H
0.1
1781.3
|
| Airsculpt Tech Inc |
|
272.3
|
3.9
|
L
 11.6%
H
3.4
3.9
|
L
 44.0%
H
2.7
3.9
|
L
 31.3%
H
2.3
3.9
|
L
 70.0%
H
1.5
3.9
|
L
 50.8%
H
1.5
12
|
L
 -23.9%
H
1.5
12
|
L
H
1.5
18.5
|
L
H
1.5
18.5
|
| Align Tech |
|
12,055.1
|
168.8
|
L
 0.2%
H
163.3
169.2
|
L
 -4.1%
H
163.3
179.4
|
L
 1.1%
H
163.3
200.4
|
L
 -10.0%
H
162.3
200.4
|
L
 -2%
H
122
208.3
|
L
 -46.2%
H
122
413.2
|
L
 -71.8%
H
122
737.5
|
L
 125.9%
H
74.5
737.5
|
| Angiodynamic Inc |
|
462.8
|
11.2
|
L
 -0.6%
H
11.1
11.4
|
L
 2.4%
H
10.8
11.4
|
L
 15.5%
H
9.7
11.4
|
L
 6.1%
H
9.4
12.0
|
L
 27.7%
H
8.4
14.0
|
L
 28.4%
H
5.3
14.0
|
L
 -53.5%
H
5.3
32
|
L
 -10.1%
H
5.3
32
|
| Anika Therapeutics Inc |
|
196.5
|
14.8
|
L
 -2.4%
H
14.8
15.4
|
L
 18.6%
H
13.5
15.4
|
L
 -1.0%
H
11.9
16.2
|
L
 41.2%
H
9.9
16.2
|
L
 1.9%
H
7.9
16.2
|
L
 -42.9%
H
7.9
29.1
|
L
 -64.8%
H
7.9
48.4
|
L
 -66.5%
H
7.9
75.7
|
| Apyx Medical Corp |
|
153.5
|
3.7
|
L
 3.1%
H
3.4
3.8
|
L
 10.2%
H
2.8
3.8
|
L
 -2.1%
H
2.8
4.2
|
L
 -5.4%
H
2.8
4.2
|
L
 193.6%
H
1.1
4.5
|
L
 6.7%
H
0.8
8.0
|
L
 -61.8%
H
0.8
17.5
|
L
 98.4%
H
0.8
17.5
|
| Accuray Inc |
|
47.2
|
0.4
|
L
 31.0%
H
0.3
0.4
|
L
 -19.2%
H
0.3
0.5
|
L
H
0.3
0.5
|
L
 -38.7%
H
0.3
0.6
|
L
 -72.1%
H
0.3
2.1
|
L
 -89.3%
H
0.3
4.3
|
L
 -92.1%
H
0.3
5.9
|
L
 -92.5%
H
0.3
6.4
|
| Alphatec Holdings Inc |
|
1,156.5
|
7.5
|
L
 -3.0%
H
7.5
8
|
L
 -23.0%
H
6.9
10.8
|
L
 -31.8%
H
6.9
11.8
|
L
 -45.6%
H
6.9
14.7
|
L
 -39.6%
H
6.9
23.3
|
L
 -50.4%
H
4.9
23.3
|
L
 -50.2%
H
4.9
23.3
|
L
 193.8%
H
1.2
23.3
|
| Atricure Inc |
|
1,270.2
|
26.3
|
L
 -5.5%
H
26.1
28.0
|
L
 -6.5%
H
26.1
29.6
|
L
 -9.0%
H
26.1
30.5
|
L
 -29.2%
H
26.1
38.1
|
L
 -13.3%
H
26.1
43.2
|
L
 -45.6%
H
18.9
59.6
|
L
 -66.2%
H
18.9
89.2
|
L
 88.3%
H
13.4
89.2
|
| Axogen Inc |
|
2,236.7
|
42.1
|
L
 -3.1%
H
41.7
43.5
|
L
 -2.6%
H
41.7
44.5
|
L
 35.7%
H
31.8
45.8
|
L
 20.4%
H
27.5
45.8
|
L
 156.6%
H
9.2
45.8
|
L
 346.5%
H
3.5
45.8
|
L
 79.0%
H
3.5
45.8
|
L
 644.4%
H
3.5
56.9
|
| Bone Biologics Corp |
|
2.4
|
1.3
|
L
 2.3%
H
1.3
1.3
|
L
 2.3%
H
1.3
1.4
|
L
 6.5%
H
1.2
1.4
|
L
 -5.7%
H
1.1
1.4
|
L
 -67%
H
1.1
6.8
|
L
 -99.5%
H
1.1
432.2
|
L
 -100.0%
H
1.1
10255.5
|
L
 -100.0%
H
1.1
169920
|
| BioAffinity Tech Inc |
|
9.1
|
2.0
|
L
 -4.3%
H
2.0
2.1
|
L
 -18.2%
H
1.8
2.4
|
L
 -50.4%
H
1.8
4.3
|
L
 138.8%
H
0.8
5.4
|
L
 -68.2%
H
0.7
15
|
L
 -96.7%
H
0.7
108.6
|
L
H
0.7
466.5
|
L
H
0.7
466.5
|
| Bluejay Diagnostics Inc |
|
1.8
|
1.7
|
L
 -5.5%
H
1.7
1.8
|
L
 -5.0%
H
1.7
2.1
|
L
 -16.1%
H
1.7
2.1
|
L
 -49.3%
H
1.7
3.6
|
L
 -75.0%
H
1.7
16.7
|
L
 -100.0%
H
1.7
22368
|
L
H
1.7
200000
|
L
H
1.7
200000
|
| Biolife Soln Inc |
|
1,076.8
|
22.0
|
L
 -4.7%
H
20.8
23.1
|
L
 4.6%
H
20.6
23.2
|
L
 15.2%
H
19.5
23.2
|
L
 -1.7%
H
17.9
25.3
|
L
 3.3%
H
17.9
29.6
|
L
 14.0%
H
8.9
29.6
|
L
 -30.4%
H
8.9
60.7
|
L
 1159.4%
H
1.4
60.7
|
| Biomerica Inc |
|
6.9
|
2.2
|
L
 0.9%
H
2.2
2.2
|
L
 1.8%
H
2.1
2.2
|
L
 2.8%
H
2.0
2.2
|
L
 -1.3%
H
1.9
2.3
|
L
 -36.0%
H
1.9
4.6
|
L
 53.1%
H
0.2
4.9
|
L
 -49.5%
H
0.2
7.4
|
L
 40.5%
H
0.2
23.4
|
| Bruker Corp |
|
6,721.2
|
44.2
|
L
 1.0%
H
42.1
44.4
|
L
 20.3%
H
35.7
44.4
|
L
 20.4%
H
33.8
44.4
|
L
 5.3%
H
32.4
44.4
|
L
 8.3%
H
28.5
56.2
|
L
 -43.8%
H
28.5
94.9
|
L
 -36.3%
H
28.5
94.9
|
L
 59.9%
H
19.6
94.9
|
| BioRestorative Therapies Inc |
|
5.4
|
0.2
|
L
 -4.6%
H
0.2
0.2
|
L
 -4.6%
H
0.2
0.3
|
L
 -16%
H
0.2
0.3
|
L
 -79.8%
H
0.2
1.1
|
L
 -88.3%
H
0.2
2.0
|
L
 -95.2%
H
0.2
7.1
|
L
 -99.4%
H
0.2
40
|
L
 -100.0%
H
0.2
20040
|
| Biosig Tech Inc |
|
90.9
|
0.9
|
L
 -4.1%
H
0.9
1.0
|
L
 22.4%
H
0.7
1.3
|
L
 -16.2%
H
0.7
1.3
|
L
 -71.7%
H
0.7
3.4
|
L
 -36.7%
H
0.7
14.1
|
L
 -30.6%
H
0.1
14.1
|
L
 -71.0%
H
0.1
14.1
|
L
 -78.6%
H
0.1
14.1
|
| Bioventus Inc (Class A) |
|
706.6
|
10.5
|
L
 -1.4%
H
10.3
10.9
|
L
 6.4%
H
9.7
11.3
|
L
 18.8%
H
8.9
11.3
|
L
 23.4%
H
7.8
11.3
|
L
 59.3%
H
5.8
11.3
|
L
 971.4%
H
1.0
14.4
|
L
 -28.3%
H
0.8
19.9
|
L
H
0.8
19.9
|
| Brainsway Ltd (ADR) |
|
687.4
|
17.2
|
L
 2.8%
H
16.8
17.3
|
L
 3.7%
H
16.2
17.3
|
L
 40.1%
H
12.6
17.3
|
L
 215.6%
H
5.4
17.3
|
L
 687.6%
H
2.2
17.3
|
L
 4418.4%
H
0.3
17.3
|
L
 694.9%
H
0.3
17.3
|
L
H
0.3
17.3
|
| Cardio Diagnostics Holdings Inc |
|
5.4
|
1.8
|
L
 1.1%
H
1.8
1.9
|
L
 2.2%
H
1.7
2.4
|
L
 -9.9%
H
1.7
2.4
|
L
 41.9%
H
1.2
7.9
|
L
 -84.8%
H
1.0
7.9
|
L
 -96.9%
H
1.0
106.8
|
L
H
1.0
307.5
|
L
H
1.0
307.5
|
| Caredx Inc |
|
1,127.2
|
21.8
|
L
 1.8%
H
21.0
22.3
|
L
 4.9%
H
20.4
22.3
|
L
 23.5%
H
15.6
23.2
|
L
 12.1%
H
15.6
23.2
|
L
 47.7%
H
11.0
23.2
|
L
 160.1%
H
4.8
34.8
|
L
 -71.9%
H
4.8
96.9
|
L
 400.5%
H
0.8
99.8
|
| Celcuity Inc |
|
6,335.0
|
131.1
|
L
 0.3%
H
129.2
133.4
|
L
 8%
H
117.5
151.0
|
L
 13.4%
H
106.6
151.0
|
L
 22.8%
H
97.5
151.0
|
L
 1187.4%
H
9.5
151.0
|
L
 1253.9%
H
7.6
151.0
|
L
 382.9%
H
4.8
151.0
|
L
H
4.0
151.0
|
| Creative Medical Tech Holdings Inc |
|
8.5
|
2.3
|
L
 0.9%
H
2.1
2.4
|
L
 2.7%
H
2.1
2.4
|
L
 2.7%
H
2.0
2.5
|
L
 19.7%
H
1.8
2.5
|
L
 19.7%
H
1.5
6.3
|
L
 -63.9%
H
1.5
10.3
|
L
 -98.7%
H
1.5
215
|
L
 -100.0%
H
1.5
525000
|
| Cerus Corp |
|
523.0
|
2.6
|
L
H
2.5
2.7
|
L
 28.6%
H
2.5
3.2
|
L
 41.9%
H
1.8
3.2
|
L
 18.6%
H
1.6
3.2
|
L
 100.8%
H
1.2
3.2
|
L
 14.5%
H
1.1
3.2
|
L
 -57.5%
H
1.1
8.1
|
L
 -52.6%
H
1.1
8.9
|
| Check-Cap Ltd |
|
10.2
|
1.5
|
L
 -2.7%
H
1.5
1.5
|
L
 -1.4%
H
1.3
1.5
|
L
 -11.0%
H
1.3
2.0
|
L
 -12.7%
H
1.3
2.2
|
L
 48.0%
H
0.6
3.9
|
L
 4.3%
H
0.6
4.6
|
L
 -95.1%
H
0.6
38.2
|
L
 -99.8%
H
0.6
157248.0
|
| CollPlant biotech Ltd - Ordinary Shares New |
|
5.8
|
0.4
|
L
 2.6%
H
0.4
0.4
|
L
 5.3%
H
0.4
0.4
|
L
 11.1%
H
0.3
0.5
|
L
 -50%
H
0.3
0.9
|
L
 -78.5%
H
0.3
5.0
|
L
 -94.1%
H
0.3
8.9
|
L
 -97.1%
H
0.3
23.5
|
L
 -97.9%
H
0.3
24.3
|
| ClearPoint Neuro Inc |
|
384.4
|
12.8
|
L
 9.8%
H
11.4
13.1
|
L
 14.7%
H
10.7
13.1
|
L
 41.4%
H
8.3
13.1
|
L
 -4.8%
H
8.3
15.3
|
L
 -3.5%
H
8.3
30.1
|
L
 34.1%
H
4.1
30.1
|
L
 -32.3%
H
4.1
30.1
|
L
 -14.5%
H
1.3
31.3
|
| Cardiff Oncology Inc |
|
112.1
|
1.6
|
L
 2.5%
H
1.6
1.7
|
L
 -5.2%
H
1.6
1.8
|
L
 5.1%
H
1.5
1.8
|
L
 2.5%
H
1.5
2.1
|
L
 -34.1%
H
1.5
4.6
|
L
 -12.8%
H
0.9
6.4
|
L
 -82.7%
H
0.9
9.7
|
L
 -99.4%
H
0.7
430.6
|
| Castle Biosciences Inc |
|
592.7
|
19.8
|
L
 3.1%
H
18.7
19.9
|
L
 -19.0%
H
18.3
25.7
|
L
 -20.1%
H
18.3
26.7
|
L
 -39.5%
H
18.3
34.4
|
L
 16.3%
H
14.6
44.3
|
L
 -10.9%
H
9.3
44.3
|
L
 -67.1%
H
9.3
78.9
|
L
H
9.3
107.7
|
| Cytek BioSciences Inc |
|
595.3
|
4.6
|
L
 -6.3%
H
4.2
4.8
|
L
 1.1%
H
4.2
5.0
|
L
 0.2%
H
4.1
5.0
|
L
 3.1%
H
4.0
5.0
|
L
 23.6%
H
2.4
6.2
|
L
 -61.3%
H
2.4
11.9
|
L
H
2.4
28.7
|
L
H
2.4
28.7
|
| Cytosorbents Corp |
|
38.3
|
0.6
|
L
H
0.6
0.6
|
L
H
0.6
0.7
|
L
H
0.6
0.7
|
L
 -9.0%
H
0.5
0.8
|
L
 -30.7%
H
0.5
1.4
|
L
 -78.1%
H
0.5
4.3
|
L
 -92.7%
H
0.5
9.8
|
L
 -86.0%
H
0.5
15.0
|
| Citius Pharma Inc |
|
17.6
|
0.6
|
L
 -1.5%
H
0.6
0.7
|
L
 -8.6%
H
0.6
0.7
|
L
 -19.0%
H
0.6
1.0
|
L
 -15.8%
H
0.6
1.1
|
L
 -8.6%
H
0.6
2.5
|
L
 -98%
H
0.1
36.3
|
L
 -98.8%
H
0.1
114
|
L
 -99.9%
H
0.1
543.8
|
| CVRx Inc |
|
179.7
|
6.8
|
L
 -6.7%
H
6.7
7.2
|
L
 -9.1%
H
6.7
8.1
|
L
 -18.4%
H
6.5
8.8
|
L
 4.3%
H
4.4
9.8
|
L
 -8.7%
H
4.3
11.3
|
L
 -45.8%
H
4.3
33.1
|
L
H
4.3
33.1
|
L
H
4.3
33.1
|
| Delcath Systems Inc |
|
395.5
|
11.5
|
L
 2.1%
H
11.0
11.5
|
L
 10.6%
H
10.4
12.3
|
L
 18.7%
H
9.7
12.3
|
L
 22.5%
H
8.5
12.3
|
L
 -1.1%
H
8.1
18.2
|
L
 90.1%
H
2.3
18.2
|
L
 5.5%
H
2.3
18.2
|
L
 -100.0%
H
2.3
838880000
|
| Alpha Tau Medical Ltd |
|
749.0
|
8.5
|
L
 8.4%
H
7.7
8.6
|
L
 2.0%
H
7.2
9.1
|
L
 19.2%
H
7.1
9.1
|
L
 19.7%
H
6.1
9.1
|
L
 212.9%
H
2.6
9.1
|
L
 187.5%
H
1.8
9.1
|
L
H
1.8
20.7
|
L
H
1.8
20.7
|
| DexCom |
|
23,387.8
|
60.6
|
L
 -0.5%
H
60.1
61.4
|
L
 1.8%
H
58.7
62.9
|
L
 -4.0%
H
56.7
66.4
|
L
 -13.4%
H
56.7
74.5
|
L
 -27.3%
H
54.1
90.0
|
L
 -49.8%
H
54.1
142
|
L
 -32.4%
H
54.1
164.9
|
L
 295.4%
H
10.7
164.9
|
| Daxor Corp |
|
58.0
|
10.0
|
L
 3%
H
9.8
10.4
|
L
 -7.9%
H
9.1
11.5
|
L
 12.2%
H
8.6
12.3
|
L
 -19.4%
H
8.6
12.9
|
L
 33.2%
H
7.1
14.8
|
L
 -16.9%
H
6.6
14.8
|
L
 6.4%
H
6.6
15.5
|
L
 24.4%
H
3.4
24.1
|
| ElectroCore Inc |
|
57.4
|
6.4
|
L
 2.2%
H
6.2
6.5
|
L
 -1.5%
H
6.2
7.3
|
L
 -4.5%
H
5.7
7.3
|
L
 17.6%
H
5.2
8.2
|
L
 -5.9%
H
4.2
8.6
|
L
 11.3%
H
3.8
19.5
|
L
 -71.5%
H
2.9
27.8
|
L
H
2.9
303.8
|
| ChronoScale Corp |
|
2,228.0
|
15.6
|
L
 3.8%
H
15.1
16.1
|
L
 29.6%
H
10.6
16.4
|
L
 71.9%
H
7.9
16.4
|
L
 49.6%
H
7.9
16.4
|
L
 -84.2%
H
2.7
146.3
|
L
 -95.7%
H
2.7
704.0
|
L
 -98.7%
H
2.7
1379.3
|
L
 -99.9%
H
2.7
24232.5
|
| Embecta Corp |
|
216.0
|
3.6
|
L
 1.1%
H
3.5
3.8
|
L
 -60.2%
H
3.5
9.4
|
L
 -58.8%
H
3.5
9.9
|
L
 -66.5%
H
3.5
10.9
|
L
 -70.8%
H
3.5
15.6
|
L
 -87.5%
H
3.5
32
|
L
H
3.5
63
|
L
H
3.5
63
|
| Establishment Labs Holdings Inc |
|
2,149.3
|
71.8
|
L
 -0.4%
H
70.3
72.9
|
L
 4.6%
H
64.4
76.5
|
L
 21.6%
H
59.9
76.5
|
L
 4.3%
H
53.2
83.3
|
L
 115.7%
H
33.3
83.3
|
L
 6.0%
H
17
83.3
|
L
 0.3%
H
17
93.8
|
L
H
7.6
93.8
|
| EDAP TMS S.A. (ADR) |
|
154.8
|
4.1
|
L
 -0.7%
H
4.0
4.3
|
L
 24.4%
H
3.2
4.3
|
L
 21.5%
H
3.1
4.3
|
L
 -12.7%
H
3.1
5.1
|
L
 79.6%
H
1.2
5.1
|
L
 -65.4%
H
1.2
12.1
|
L
 -38.3%
H
1.2
12.7
|
L
 22.6%
H
1.2
12.7
|
| GlucoTrack Inc |
|
2.9
|
0.8
|
L
 -7.0%
H
0.8
0.9
|
L
 -5.9%
H
0.7
1.2
|
L
 17.7%
H
0.6
1.3
|
L
 -54.0%
H
0.6
1.9
|
L
 -92.2%
H
0.6
15.9
|
L
 -100.0%
H
0.6
5940
|
L
 -100.0%
H
0.6
46800
|
L
 -100.0%
H
0.6
468000
|
| GE HealthCare Tech |
|
28,872.0
|
63.5
|
L
 3.5%
H
62
63.5
|
L
 4.3%
H
59.8
63.5
|
L
 -9.0%
H
58.8
76.0
|
L
 -21.3%
H
58.8
87.1
|
L
 -7.8%
H
58.8
89.8
|
L
 -19.6%
H
57.7
94.8
|
L
H
53
94.8
|
L
H
53
94.8
|
| Harvard Bioscience Inc |
|
31.1
|
6.9
|
L
 1.6%
H
6.8
7.1
|
L
 8.2%
H
6.1
7.5
|
L
 27.8%
H
4.3
7.5
|
L
 39.4%
H
4
7.5
|
L
 130%
H
2.8
9.5
|
L
 -88.8%
H
2.8
62.1
|
L
 -90.6%
H
2.8
87.5
|
L
 -75.5%
H
2.8
87.5
|
| Heart Test Laboratories Inc |
|
6.1
|
1.9
|
L
 -0.5%
H
1.9
2.0
|
L
 -1.0%
H
1.8
2.1
|
L
 -12.3%
H
1.8
2.4
|
L
 -35.5%
H
1.8
3.3
|
L
 -44.2%
H
1.8
6.5
|
L
 -97.8%
H
1.8
132
|
L
H
1.8
600
|
L
H
1.8
600
|
| Helius Medical Tech Inc (Class A) |
|
121.9
|
2.2
|
L
 3.3%
H
2.1
2.2
|
L
 8.8%
H
2.0
2.3
|
L
 21.3%
H
1.8
2.4
|
L
 1.4%
H
1.6
2.4
|
L
 -98.9%
H
1.6
258.5
|
L
 -100.0%
H
1.6
10836.4
|
L
 -100.0%
H
1.6
647250
|
L
 -100.0%
H
1.6
27168750
|
| Henry Schein |
|
8,067.6
|
70.8
|
L
 0.5%
H
69.3
71.4
|
L
 -5.1%
H
69.3
76.0
|
L
 -4.1%
H
69.3
81.1
|
L
 -11.2%
H
69.3
89.3
|
L
 6.4%
H
61.9
89.3
|
L
 -11.2%
H
60.0
89.3
|
L
 -12.1%
H
60.0
92.7
|
L
 6.3%
H
41.9
92.7
|
| Hyperfine Inc (Class A) |
|
166.5
|
1.7
|
L
 0.6%
H
1.7
1.8
|
L
 1.8%
H
1.7
1.9
|
L
 52.3%
H
1.1
1.9
|
L
 53.6%
H
1.0
1.9
|
L
 138.0%
H
0.5
2.2
|
L
 15.8%
H
0.5
3.3
|
L
 -83.0%
H
0.5
16.6
|
L
H
0.5
16.6
|
| Integra Lifesciences Holdings Corp |
|
1,082.9
|
13.9
|
L
 2.7%
H
13.4
14.0
|
L
 32.1%
H
10.4
14.4
|
L
 49.2%
H
9.2
14.4
|
L
 23.6%
H
8.7
14.4
|
L
 9.4%
H
8.7
16.5
|
L
 -72.6%
H
8.7
51.1
|
L
 -81.2%
H
8.7
76.7
|
L
 -61.3%
H
8.7
77.4
|
| Icecure Medical Ltd |
|
19.5
|
0.2
|
L
 -4%
H
0.2
0.3
|
L
 -17.2%
H
0.2
0.3
|
L
 -27.3%
H
0.2
0.4
|
L
 -59.3%
H
0.2
0.7
|
L
 -77.4%
H
0.2
1.4
|
L
 -80%
H
0.2
1.7
|
L
 -98.1%
H
0.2
14
|
L
 -79.1%
H
0.2
16
|
| SeaStar Medical Holding Corp |
|
17.9
|
4.5
|
L
 -7.6%
H
4.4
4.9
|
L
 8.5%
H
4.2
5.1
|
L
 7.7%
H
3.6
5.1
|
L
 81.1%
H
2.1
5.1
|
L
 -96.4%
H
2.1
134
|
L
 -99.9%
H
2.1
5112.5
|
L
 -100.0%
H
2.1
55000
|
L
H
2.1
55000
|
| ICU Medical Inc |
|
3,159.8
|
126.4
|
L
 2.7%
H
123.1
130.4
|
L
 6.1%
H
115.6
130.4
|
L
 5.5%
H
113.4
131.8
|
L
 -18.0%
H
113.4
159.9
|
L
 -6%
H
107
160.3
|
L
 -31.5%
H
78.4
212.4
|
L
 -36.7%
H
78.4
282
|
L
 24.1%
H
78.4
321.7
|
| Idexx Laboratories |
|
44,183.2
|
560.1
|
L
 -2.1%
H
555.2
572.2
|
L
 -0.1%
H
550
585.1
|
L
 -2.6%
H
544.0
605.8
|
L
 -13.1%
H
544.0
666.1
|
L
 15.1%
H
485.4
770.0
|
L
 14.7%
H
356.3
770.0
|
L
 2.9%
H
317.1
770.0
|
L
 546.9%
H
86.0
770.0
|
| Inspira Tech Oxy B.H.N. Ltd |
|
18.7
|
0.4
|
L
 -4.4%
H
0.4
0.5
|
L
 -2.3%
H
0.4
0.5
|
L
 2.4%
H
0.4
0.7
|
L
 -39.4%
H
0.3
0.8
|
L
 -20.4%
H
0.3
1.7
|
L
 -67.2%
H
0.3
2.5
|
L
H
0.3
9.6
|
L
H
0.3
9.6
|
| Intercure Ltd |
|
45.9
|
0.8
|
L
H
0.8
0.9
|
L
H
0.8
0.9
|
L
 12%
H
0.7
0.9
|
L
 -4.6%
H
0.7
1.0
|
L
 -47.5%
H
0.7
1.8
|
L
 -63.0%
H
0.7
3.7
|
L
 -86.9%
H
0.7
8.8
|
L
H
0.7
19.4
|
| Inogen Inc |
|
191.8
|
7.0
|
L
 -2.4%
H
6.6
7.4
|
L
 -1.3%
H
6.6
7.4
|
L
 3.2%
H
6.1
7.7
|
L
 24.0%
H
5.3
7.7
|
L
 -2.1%
H
5.3
9.1
|
L
 -46.0%
H
4.1
13.5
|
L
 -89.5%
H
4.1
82.4
|
L
 -85.5%
H
4.1
287.8
|
| Inmode Ltd |
|
885.1
|
14.0
|
L
 0.3%
H
13.9
14.2
|
L
 -3.5%
H
13.3
14.5
|
L
 2.3%
H
13.3
14.8
|
L
 -7.4%
H
12.7
15.4
|
L
 -1.8%
H
12.7
16.7
|
L
 -58.6%
H
12.7
48.3
|
L
 -63.8%
H
12.7
99.3
|
L
H
6.5
99.3
|
| NAYA Biosciences |
|
2.8
|
1.7
|
L
 -5.5%
H
1.7
1.8
|
L
 -8.5%
H
1.7
2.0
|
L
 -17.3%
H
1.7
2.4
|
L
 -68.7%
H
1.7
6.3
|
L
 -99.3%
H
1.7
297.6
|
L
 -100.0%
H
1.7
12384
|
L
 -100.0%
H
1.7
156314.9
|
L
 -100.0%
H
1.7
709632
|
| IRIDEX Corp |
|
17.9
|
1.0
|
L
H
1.0
1.0
|
L
H
1.0
1.1
|
L
H
1.0
1.2
|
L
 -29.5%
H
1.0
1.5
|
L
 -10.4%
H
0.9
1.7
|
L
 -54.8%
H
0.8
3.7
|
L
 -86.8%
H
0.8
9.5
|
L
 -90.7%
H
0.8
16.6
|
| Iradimed Corp |
|
1,102.9
|
86.3
|
L
 -0.5%
H
85.7
87.4
|
L
 3.4%
H
77.0
88.7
|
L
 -7.7%
H
77.0
98.2
|
L
 -10.1%
H
77.0
107.9
|
L
 69.1%
H
50.9
107.9
|
L
 84.3%
H
36.1
107.9
|
L
 197.0%
H
26
107.9
|
L
 420.1%
H
7.9
107.9
|
| iRhythm Tech Inc |
|
3,965.2
|
120.7
|
L
 -3.4%
H
118
125.1
|
L
 -6.6%
H
113.9
130.0
|
L
 1.7%
H
113.9
130.0
|
L
 -17.6%
H
112.3
164.7
|
L
 -11.4%
H
112.3
212
|
L
 -3.3%
H
55.9
212
|
L
 50.8%
H
41.7
212
|
L
H
22.2
286.2
|
| Intuitive Surgical |
|
159,394.5
|
450.1
|
L
 -0.8%
H
447
454.3
|
L
 -1.7%
H
442.0
463.1
|
L
 -0.6%
H
442.0
491.2
|
L
 -7.8%
H
442.0
511.9
|
L
 -16.1%
H
427.8
603.9
|
L
 47.6%
H
254.9
616
|
L
 57.5%
H
180.1
616
|
L
 554.4%
H
67.9
616
|
| Jowell Global Ltd |
|
6.1
|
2.6
|
L
H
2.5
2.6
|
L
 0.8%
H
2.3
2.6
|
L
 4.1%
H
2.2
2.8
|
L
 23.2%
H
1.9
2.8
|
L
 26.9%
H
1.5
3.0
|
L
 -47.7%
H
1
5.6
|
L
 -97.9%
H
1
412.5
|
L
H
1
412.5
|
| Kewaunee Scientific Corp |
|
106.1
|
37.0
|
L
 1.5%
H
35.4
37.6
|
L
H
35.3
39
|
L
 8.9%
H
33.9
39
|
L
 -9.2%
H
33.7
43.4
|
L
 13.8%
H
32.6
60.9
|
L
 125.3%
H
14.6
71.3
|
L
 207.1%
H
11.4
71.3
|
L
 127.1%
H
7.0
71.3
|
| OrthoPediatrics corp |
|
457.4
|
17.8
|
L
 1.4%
H
17.2
17.9
|
L
 18.3%
H
14.5
17.9
|
L
 13.0%
H
14.4
18.4
|
L
 7.0%
H
14.4
20.2
|
L
 -19.7%
H
14.4
23.7
|
L
 -61.6%
H
14.4
48.5
|
L
 -72.2%
H
14.4
73.9
|
L
H
14
73.9
|
| KORU Medical Systems Inc |
|
194.7
|
4.2
|
L
 -5.4%
H
4.1
4.4
|
L
 5.3%
H
3.9
4.7
|
L
 -0.9%
H
3.9
4.7
|
L
 -14.6%
H
3.9
5.1
|
L
 54.4%
H
2.6
6.6
|
L
 4.7%
H
1.9
6.6
|
L
 17.3%
H
1.8
6.6
|
L
 1066.7%
H
0.3
12.8
|
| Standard BioTools Inc |
|
396.0
|
1.0
|
L
 2%
H
1.0
1.0
|
L
 9.7%
H
0.9
1.0
|
L
 10.9%
H
0.9
1.0
|
L
 -19.1%
H
0.9
1.3
|
L
H
0.9
1.7
|
L
 -37.0%
H
0.9
3.2
|
L
 -80.1%
H
0.9
7.5
|
L
 -88.9%
H
0.9
14.9
|
| LivaNova PLC |
|
3,929.9
|
71.9
|
L
 1.3%
H
70.3
72.5
|
L
 19.6%
H
56.4
72.5
|
L
 13.1%
H
56.4
72.5
|
L
 8.0%
H
56.4
72.5
|
L
 65.2%
H
41.0
72.5
|
L
 51.3%
H
32.5
72.5
|
L
 -13.4%
H
32.5
93.9
|
L
 41.7%
H
32.5
131.5
|
| Lemaitre Vascular Inc |
|
2,466.5
|
107.9
|
L
 0.0%
H
105.3
109.7
|
L
 -1.7%
H
103.2
115.8
|
L
 -2.2%
H
103.2
118.0
|
L
 23.5%
H
85.4
118.0
|
L
 32.3%
H
78.4
118.0
|
L
 59.7%
H
44.3
118.0
|
L
 112.2%
H
38.3
118.0
|
L
 576.7%
H
13.5
118.0
|
| LENSAR Inc |
|
68.3
|
5.6
|
L
 7.8%
H
5.2
6.0
|
L
 7.8%
H
5.2
6.0
|
L
 0.2%
H
5.1
6.3
|
L
 -53.3%
H
5.1
12.6
|
L
 -59.2%
H
5.1
14.3
|
L
 112.0%
H
1.8
17.3
|
L
 -21.0%
H
1.8
17.3
|
L
H
1.8
17.3
|
| Lantheus Holdings Inc |
|
6,058.4
|
93.1
|
L
 2.3%
H
91.7
94.9
|
L
 10.0%
H
83.7
94.9
|
L
 19.2%
H
78.7
94.9
|
L
 43.4%
H
63.5
94.9
|
L
 15.6%
H
47.3
94.9
|
L
 -1.1%
H
47.3
126.9
|
L
 323.6%
H
19.3
126.9
|
L
 4331.4%
H
1.9
126.9
|
| Lucid Diagnostics Inc |
|
201.1
|
1.0
|
L
 -1.9%
H
1.0
1.1
|
L
 -3.7%
H
1.0
1.1
|
L
 -8.0%
H
1.0
1.4
|
L
 -15.6%
H
1.0
1.5
|
L
 -13.5%
H
1.0
1.7
|
L
 -31.3%
H
0.6
1.9
|
L
H
0.6
13.5
|
L
H
0.6
13.5
|
| Pulmonx Corp |
|
53.2
|
1.3
|
L
 -0.8%
H
1.2
1.3
|
L
 -1.6%
H
1.2
1.5
|
L
 -1.6%
H
1.2
1.6
|
L
 -16%
H
1.1
2.2
|
L
 -65.8%
H
1.1
3.9
|
L
 -89.7%
H
1.1
14.8
|
L
 -97.0%
H
1.1
45.8
|
L
H
1.1
69.5
|
| Masimo Corp |
|
9,337.9
|
178.3
|
L
 -0.1%
H
178.3
178.6
|
L
 -0.1%
H
178.2
178.7
|
L
 -0.2%
H
178.2
178.9
|
L
 28.1%
H
129.2
179
|
L
 18.8%
H
125.9
179
|
L
 -5.1%
H
75.2
194.9
|
L
 -20.5%
H
75.2
305.2
|
L
 286.9%
H
45.7
305.2
|
| 908 Devices Inc |
|
300.8
|
8.2
|
L
 1.1%
H
7.8
8.2
|
L
 19.6%
H
6.5
8.2
|
L
 20.9%
H
6.4
8.2
|
L
 24.7%
H
5.7
8.2
|
L
 50.5%
H
4.2
9.3
|
L
 15.2%
H
1.8
12.5
|
L
 -83.8%
H
1.8
51.0
|
L
H
1.8
79.6
|
| Mimedx Grp Inc |
|
536.2
|
3.6
|
L
 -2.4%
H
3.6
3.7
|
L
 7.1%
H
3.4
3.7
|
L
 -6.7%
H
3.0
4.1
|
L
 -30.1%
H
3.0
5.5
|
L
 -48.4%
H
3.0
8.0
|
L
 -37.3%
H
3.0
10.1
|
L
 -63.8%
H
2.4
16.0
|
L
 -49.2%
H
1.0
18.3
|
| Mesa Laboratories Inc |
|
578.2
|
104.7
|
L
 -1.4%
H
98.1
105.9
|
L
 4.7%
H
97.2
109.5
|
L
 11.1%
H
89.2
109.5
|
L
 12.2%
H
71.1
109.5
|
L
 -13%
H
55.5
131.2
|
L
 -37.2%
H
55.5
166.0
|
L
 -58.4%
H
55.5
333.4
|
L
 -1.7%
H
55.5
333.4
|
| Merit Medical Systems Inc |
|
3,655.1
|
61.3
|
L
 -1.7%
H
61.2
64.1
|
L
 -10.1%
H
59.7
68.2
|
L
 -9.1%
H
59.7
71.9
|
L
 -25.7%
H
59.7
84.0
|
L
 -35.0%
H
59.7
100.2
|
L
 -27.8%
H
59.7
111.5
|
L
 -5.2%
H
50.5
111.5
|
L
 214.0%
H
18.2
111.5
|
| Modular Medical Inc |
|
20.5
|
3.8
|
L
 -4.3%
H
3.7
4.1
|
L
 -12.9%
H
3.7
4.5
|
L
 -27.9%
H
3.7
5.9
|
L
 -71.2%
H
3.5
16.2
|
L
 -87.8%
H
3.5
31.2
|
L
 -92.9%
H
3.5
79.5
|
L
 -99.0%
H
3.5
585.0
|
L
 -84.4%
H
3.5
585.0
|
| Myriad Genetics Inc |
|
405.2
|
4.3
|
L
 4.9%
H
4
4.4
|
L
 -9.7%
H
3.8
5.1
|
L
 -9.5%
H
3.8
5.4
|
L
 -16.2%
H
3.8
5.7
|
L
 0.5%
H
3.8
8.6
|
L
 -77.8%
H
3.8
29.3
|
L
 -84.8%
H
3.8
37.0
|
L
 -87.5%
H
3.8
50.4
|
| MDxHealth SA (ADR) |
|
-
|
2
|
L
 -0.5%
H
2.0
2.0
|
L
 -2.0%
H
2.0
2.2
|
L
 -1.0%
H
2.0
2.4
|
L
 -43.3%
H
2.0
3.8
|
L
 17.0%
H
1.7
5.3
|
L
 -48.6%
H
1.4
5.3
|
L
H
1.4
13.2
|
L
H
1.4
13.2
|
| ENvue Medical Inc |
|
4.4
|
1.2
|
L
 -9.9%
H
1.2
1.5
|
L
 2.6%
H
1.1
1.5
|
L
 -34.6%
H
1.1
1.9
|
L
 -59.3%
H
1.1
3.8
|
L
 -97.3%
H
0.7
44.5
|
L
 -99.7%
H
0.7
477.4
|
L
 -99.9%
H
0.7
9218
|
L
 -100.0%
H
0.7
18700
|
| ENDRA Life Sciences Inc |
|
6.1
|
5.0
|
L
H
5.0
5.3
|
L
 1.6%
H
4.8
5.4
|
L
 -7.3%
H
4.6
6.7
|
L
 27.3%
H
3.0
6.7
|
L
 -17.6%
H
2.9
12.0
|
L
 -94.5%
H
0.0
139.5
|
L
 -99.8%
H
0.0
2440
|
L
H
0.0
5880
|
| Neogen Corp |
|
1,969.9
|
9.1
|
L
 -2.2%
H
8.9
9.3
|
L
 -3.7%
H
8.9
9.6
|
L
 -9.3%
H
8.9
10.8
|
L
 -16.2%
H
8.2
11.4
|
L
 52.6%
H
4.5
11.4
|
L
 -48.1%
H
3.9
24.1
|
L
 -81.0%
H
3.9
47.8
|
L
 -50.1%
H
3.9
48.9
|
| Nephros Inc |
|
38.2
|
3.5
|
L
 9.0%
H
2.9
3.8
|
L
 11.4%
H
2.9
3.8
|
L
 26.6%
H
2.7
3.8
|
L
 -9.0%
H
2.7
4.3
|
L
 80.5%
H
1.9
6.4
|
L
 144.4%
H
1.1
6.4
|
L
 -52.4%
H
0.9
11.7
|
L
 23.9%
H
0.9
11.7
|
| NeuroOne Medical Tech Corp |
|
40.2
|
4.8
|
L
 4.9%
H
4.4
4.9
|
L
 1.3%
H
4.1
4.9
|
L
 -4.4%
H
3.7
5.4
|
L
 1.7%
H
3.7
5.4
|
L
 21.4%
H
3.3
7.0
|
L
 -43.7%
H
2.4
12
|
L
 -88.2%
H
2.4
47.8
|
L
H
2.4
180
|
| Nano X Imaging Ltd |
|
120.4
|
1.7
|
L
 -1.7%
H
1.7
1.8
|
L
 1.2%
H
1.7
1.9
|
L
 -24.8%
H
1.7
3.1
|
L
 -29.1%
H
1.7
3.1
|
L
 -65.0%
H
1.7
5.9
|
L
 -88.6%
H
1.7
22.7
|
L
 -94.1%
H
1.7
34.5
|
L
H
1.7
94.8
|
| NeuroPace Inc |
|
623.0
|
18.4
|
L
 -4.9%
H
18.3
19.6
|
L
 8.8%
H
16.5
19.6
|
L
 26.5%
H
14.0
19.6
|
L
 17.1%
H
12.5
19.6
|
L
 51.4%
H
7.6
19.6
|
L
 270.7%
H
3.8
19.6
|
L
 -13.2%
H
1.2
26.3
|
L
H
1.2
27.4
|
| InspireMD Inc |
|
53.9
|
1.2
|
L
 -0.9%
H
1.1
1.2
|
L
 -2.5%
H
1.0
1.2
|
L
 -17.3%
H
1.0
1.6
|
L
 -33.9%
H
1.0
2.0
|
L
 -54.9%
H
1.0
2.9
|
L
 -16.1%
H
1.0
3.9
|
L
 -77.2%
H
0.8
6.8
|
L
 -100.0%
H
0.8
341250
|
| Nortech Systems Inc |
|
35.8
|
12.9
|
L
 2.7%
H
12.2
13.1
|
L
 -5.7%
H
12.2
14.8
|
L
 -1.8%
H
12
15.4
|
L
 47.8%
H
8.5
15.4
|
L
 33.3%
H
6.5
15.4
|
L
 26.5%
H
6.5
19.2
|
L
 108.8%
H
5.5
19.6
|
L
 242.9%
H
1.7
19.6
|
| Natera Inc |
|
27,733.3
|
194.2
|
L
 -11.6%
H
192.5
217.6
|
L
 -5.8%
H
192.5
221.6
|
L
 -7.2%
H
184
221.6
|
L
 -4.3%
H
181
221.6
|
L
 21.3%
H
131.8
256.4
|
L
 259.0%
H
36.9
256.4
|
L
 90.7%
H
26.1
256.4
|
L
 1929.7%
H
7.4
256.4
|
| Nutriband Inc |
|
45.6
|
3.8
|
L
 -1.1%
H
3.7
3.9
|
L
 -2.9%
H
3.6
4.2
|
L
 -6.3%
H
3.6
4.3
|
L
 -13.8%
H
3.4
4.5
|
L
 -35.1%
H
3.4
11.7
|
L
 4.7%
H
1.5
11.8
|
L
 -76.7%
H
0.9
16.1
|
L
H
0.9
43.5
|
| Nuwellis Inc |
|
2.9
|
1.1
|
L
 -0.9%
H
1.1
1.1
|
L
 -3.5%
H
1.1
1.2
|
L
 -3.5%
H
1.1
1.3
|
L
 -58.2%
H
1.0
2.7
|
L
 -97.2%
H
1.0
43.3
|
L
 -100.0%
H
1.0
6747.3
|
L
 -100.0%
H
1.0
792330
|
L
 -100.0%
H
1.0
10000000000
|
| NovoCure Ltd |
|
2,072.0
|
17.9
|
L
 6.3%
H
16.9
18.2
|
L
 17.6%
H
15.4
18.2
|
L
 72.9%
H
10.4
18.2
|
L
 76.4%
H
9.8
18.2
|
L
 7.5%
H
9.8
20.1
|
L
 -73.8%
H
9.8
83.6
|
L
 -90.7%
H
9.8
232.8
|
L
 42.1%
H
6.0
232.8
|
| enVVeno Medical Corp |
|
6.5
|
9.9
|
L
 -2.7%
H
9.9
10.3
|
L
 -4.8%
H
9.9
11.4
|
L
 -3.8%
H
9.9
13.4
|
L
 -4.6%
H
8.7
13.4
|
L
 -92.5%
H
8.7
196.7
|
L
 -92.3%
H
8.7
244.0
|
L
 -94.9%
H
8.7
398.3
|
L
H
8.7
4935
|
| Nexalin Tech Inc |
|
7.2
|
0.4
|
L
 2.9%
H
0.4
0.4
|
L
 -2.8%
H
0.3
0.4
|
L
 -5.4%
H
0.3
0.5
|
L
 -32.7%
H
0.3
0.7
|
L
 -72%
H
0.3
2
|
L
 -58.3%
H
0.3
4.5
|
L
H
0.3
4.5
|
L
H
0.3
4.5
|
| Nyxoah SA |
|
142.3
|
3.3
|
L
 1.9%
H
3.1
3.3
|
L
 10.5%
H
2.9
3.3
|
L
 -1.2%
H
2.8
3.4
|
L
 -29.9%
H
2.8
5.2
|
L
 -48.4%
H
2.8
8.6
|
L
 -59.5%
H
2.8
20
|
L
 -85.9%
H
2.8
37
|
L
H
2.8
37
|
| Nanobiotix (ADR) |
|
2,206.1
|
45.5
|
L
 6.8%
H
40.7
45.6
|
L
 31.4%
H
30.3
45.6
|
L
 50.9%
H
29.4
45.6
|
L
 118.2%
H
22.4
45.6
|
L
 1278.5%
H
3.3
45.6
|
L
 581.0%
H
2.8
45.6
|
L
 202.1%
H
1.8
45.6
|
L
H
1.8
45.6
|
| Orchestra BioMed Holdings Inc |
|
241.9
|
4.0
|
L
 2.8%
H
3.9
4.1
|
L
 1.3%
H
3.9
4.2
|
L
 -5.2%
H
3.8
4.7
|
L
 3.3%
H
3.8
4.9
|
L
 64.2%
H
2.2
5.4
|
L
 -76.1%
H
2.2
20.2
|
L
 -61.2%
H
2.2
23.4
|
L
H
2.2
23.4
|
| Orthofix Medical Inc |
|
470.9
|
11.7
|
L
 -3.5%
H
11.5
12.6
|
L
 -0.9%
H
11.3
12.6
|
L
 -0.5%
H
11.3
13.0
|
L
 -9.0%
H
11.1
14.2
|
L
 -3.1%
H
10.2
17.0
|
L
 -37.0%
H
9.6
21.6
|
L
 -73.6%
H
9.6
45.0
|
L
 -72.9%
H
9.6
74.4
|
| Outset Medical Inc |
|
68.6
|
3.7
|
L
 -20.9%
H
3.6
4.1
|
L
 -13.4%
H
3.6
4.8
|
L
 -9.8%
H
3.6
4.8
|
L
 -17.8%
H
3
4.9
|
L
 -68.5%
H
3
22.0
|
L
 -98.8%
H
0.5
362.0
|
L
 -99.5%
H
0.5
905.0
|
L
H
0.5
1004.4
|
| Organogenesis Holdings Inc (Class A) |
|
305.0
|
2.4
|
L
 -6.3%
H
2.0
2.5
|
L
 0.9%
H
2.0
2.7
|
L
 4.9%
H
2.0
2.7
|
L
 -37.1%
H
2.0
4.1
|
L
 -54.3%
H
2.0
7.1
|
L
 11.8%
H
2.0
7.1
|
L
 -88.8%
H
1.8
21.3
|
L
H
1.8
310.9
|
| Orasure Tech Inc |
|
213.2
|
3.1
|
L
 -2.2%
H
3.0
3.1
|
L
 0.7%
H
2.9
3.2
|
L
H
2.9
3.3
|
L
 12.9%
H
2.5
3.5
|
L
 9.7%
H
2.1
3.8
|
L
 -56.3%
H
2.1
8.5
|
L
 -69.0%
H
2.1
13.6
|
L
 -53.9%
H
2.1
23.0
|
| Pacific Biosciences of California Inc |
|
437.8
|
1.4
|
L
 -14.6%
H
1.4
1.5
|
L
 -11.3%
H
1.4
1.8
|
L
 -2.1%
H
1.3
1.8
|
L
 -22.5%
H
1.2
2
|
L
 24.8%
H
0.9
2.7
|
L
 -88.4%
H
0.9
14.6
|
L
 -94.3%
H
0.9
36.4
|
L
 -83.8%
H
0.9
53.7
|
| PAVmed Inc |
|
52.1
|
7.2
|
L
 0.3%
H
7.1
7.4
|
L
 -13.7%
H
7.0
8.5
|
L
 -24.7%
H
7.0
9.8
|
L
 -33.7%
H
7.0
11.3
|
L
 -67.5%
H
6
28.4
|
L
 -97.0%
H
6
270
|
L
 -99.6%
H
6
4365
|
L
H
6
6858
|
| Pro-Dex Inc (co) |
|
189.2
|
59.3
|
L
 3.2%
H
59.1
61.6
|
L
 18.2%
H
43.3
61.6
|
L
 19.1%
H
43.3
61.6
|
L
 50.2%
H
37.1
61.6
|
L
 38.7%
H
23.5
61.6
|
L
 279.9%
H
14.5
70.3
|
L
 72.4%
H
12.4
70.3
|
L
 1603.2%
H
3.6
70.3
|
| Pulse Biosciences Inc |
|
1,301.7
|
19.1
|
L
 -2.6%
H
18.7
19.7
|
L
 -9.9%
H
18.4
21.7
|
L
 -4.4%
H
17.8
24.8
|
L
 -8.1%
H
17.5
26.3
|
L
 14.3%
H
12.6
26.3
|
L
 153.1%
H
3.8
26.3
|
L
 11.3%
H
1.2
29.2
|
L
H
1.2
45.8
|
| Axe Compute Inc |
|
31.4
|
5.7
|
L
 -5.0%
H
5.6
6.0
|
L
 -4.1%
H
4.9
6.4
|
L
 19.1%
H
3.1
10.9
|
L
 146.5%
H
1.0
10.9
|
L
 -62.6%
H
1.0
32.1
|
L
 -88.4%
H
1.0
106.8
|
L
 -98.1%
H
1.0
492
|
L
 -100.0%
H
1.0
20250
|
| Precision Optics Corp Inc |
|
50.2
|
4.6
|
L
 -3.4%
H
4.6
4.7
|
L
 8.5%
H
4.2
5.0
|
L
 17.7%
H
3.9
5.0
|
L
 -18.6%
H
3.6
5.9
|
L
 2.9%
H
3.6
6.0
|
L
 -27.9%
H
3.5
7.0
|
L
H
3.5
7.9
|
L
H
3.5
7.9
|
| Insulet |
|
10,789.0
|
154.2
|
L
 -3.9%
H
154
164.7
|
L
 -10.4%
H
148.3
178.0
|
L
 -23.9%
H
148.3
209
|
L
 -36.3%
H
148.3
275.1
|
L
 -41.7%
H
148.3
354.9
|
L
 -53.1%
H
125.8
354.9
|
L
 -34.2%
H
125.8
354.9
|
L
 417.8%
H
26.5
354.9
|
| Procept BioRobotics Corp |
|
1,445.7
|
25.4
|
L
 -0.2%
H
24.5
25.6
|
L
 5.7%
H
23.2
25.6
|
L
 9.5%
H
21.3
26.1
|
L
 -11.6%
H
19.4
30.0
|
L
 -52.2%
H
19.4
66.9
|
L
 -11.0%
H
19.4
103.8
|
L
H
15.4
103.8
|
L
H
15.4
103.8
|
| Prenetics Global Ltd (Class A) |
|
274.7
|
16.2
|
L
 1.8%
H
15.3
16.3
|
L
 -3.3%
H
15.1
17.4
|
L
 -15.4%
H
15.1
20.2
|
L
 -16.0%
H
14.6
23.6
|
L
 210.8%
H
5.1
23.6
|
L
 26.7%
H
2.9
23.6
|
L
H
2.9
131.3
|
L
H
2.9
131.3
|
| Profound Medical Corp |
|
248.6
|
6.9
|
L
 -4.3%
H
6.8
7.9
|
L
 2.2%
H
6.6
7.9
|
L
 7.4%
H
5.8
7.9
|
L
 5.6%
H
4.8
8.0
|
L
 42.4%
H
3.8
9.0
|
L
 -49.0%
H
3.8
15.5
|
L
 -66.1%
H
3.1
20.6
|
L
H
0.0
29.0
|
| QuidelOrtho Corporation |
|
736.5
|
10.8
|
L
 0.3%
H
10.4
11.3
|
L
 -12.2%
H
10.2
12.9
|
L
 -27.9%
H
10.2
18
|
L
 -62.9%
H
10.2
30.5
|
L
 -58.2%
H
10.2
39.0
|
L
 -87.8%
H
10.2
90.5
|
L
 -91.1%
H
10.2
180.1
|
L
 -33.5%
H
10.2
306.7
|
| Quanterix Corp |
|
132.5
|
2.8
|
L
 2.6%
H
2.6
2.9
|
L
 -9.9%
H
2.6
3.6
|
L
 -20.3%
H
2.6
3.8
|
L
 -53.7%
H
2.6
6.8
|
L
 -47.4%
H
2.6
8.8
|
L
 -84.8%
H
2.6
29.7
|
L
 -95.0%
H
2.6
69.2
|
L
H
2.6
92.6
|
| AVITA Medical Inc |
|
126.5
|
4.1
|
L
 -1.7%
H
4.0
4.2
|
L
 -4.9%
H
4.0
4.6
|
L
 6.2%
H
4.0
5.9
|
L
 5.4%
H
3.5
5.9
|
L
 -56.6%
H
3.2
9.8
|
L
 -74.9%
H
3.2
21.7
|
L
 -78.7%
H
3.2
22.5
|
L
 -60.1%
H
3.2
55.4
|
| Rockwell Medical Inc |
|
32.7
|
0.8
|
L
 6.4%
H
0.8
0.8
|
L
 -5.7%
H
0.7
0.9
|
L
 -12.6%
H
0.7
1.0
|
L
 -21.7%
H
0.7
1.1
|
L
 -25.9%
H
0.7
2.1
|
L
 -71.1%
H
0.7
6.2
|
L
 -91.9%
H
0.7
11.7
|
L
 -98.9%
H
0.7
116.4
|
| Vyome Holdings Inc |
|
14.5
|
2.1
|
L
 -1.9%
H
2.1
2.3
|
L
 1.5%
H
1.9
2.3
|
L
 -2.4%
H
1.9
2.4
|
L
 -24.8%
H
1.9
3.5
|
L
 488.6%
H
0.3
12.9
|
L
 -98.5%
H
0.3
162.3
|
L
 -100.0%
H
0.3
42456
|
L
H
0.3
1381560
|
| Rewalk Robotics Ltd |
|
378.7
|
6.3
|
L
 -6.8%
H
6.3
6.7
|
L
 -13.5%
H
6.3
7.5
|
L
 -4.3%
H
6.1
7.7
|
L
 1005.3%
H
0.4
7.7
|
L
 384.6%
H
0.4
7.7
|
L
 47.2%
H
0.4
9.1
|
L
 -46.7%
H
0.4
19.5
|
L
 -99.6%
H
0.4
1732.5
|
| Sanmina Corp |
|
13,311.0
|
248.4
|
L
 4.8%
H
236.3
255.2
|
L
 14.0%
H
209.5
255.2
|
L
 88.4%
H
136.9
255.2
|
L
 65.8%
H
118.1
255.2
|
L
 211.7%
H
78.4
255.2
|
L
 371.7%
H
43.4
255.2
|
L
 491.3%
H
35.1
255.2
|
L
 924.1%
H
18.3
255.2
|
| Sight Sciences Inc |
|
290.2
|
5.4
|
L
 1.7%
H
5.2
5.7
|
L
 31.5%
H
4.1
5.7
|
L
 53.7%
H
3.4
5.7
|
L
 -8.4%
H
3.4
6.2
|
L
 88.1%
H
2.8
9.2
|
L
 -46.2%
H
1.0
11.0
|
L
H
1.0
42.6
|
L
H
1.0
42.6
|
| Sotera Health Co |
|
4,499.9
|
15.8
|
L
 0.7%
H
15.5
15.9
|
L
 1.4%
H
14.3
16.2
|
L
 7.8%
H
14.3
16.5
|
L
 -11.1%
H
13.1
17.9
|
L
 20%
H
10.8
19.9
|
L
 5.1%
H
9.5
19.9
|
L
 -35.9%
H
5.8
27.4
|
L
H
5.8
30.4
|
| SI-BONE Inc |
|
542.9
|
12.3
|
L
 -5.3%
H
12.3
13.0
|
L
 -1.0%
H
12.2
13.7
|
L
 -6.8%
H
11.8
14.9
|
L
 -21.3%
H
11.8
16.9
|
L
 -29.8%
H
11.8
21.9
|
L
 -44.3%
H
11.7
29.5
|
L
 -62.6%
H
11.1
34.4
|
L
H
7.2
37.2
|
| SINTX Tech Inc |
|
9.7
|
2.4
|
L
 -1.7%
H
2.3
2.5
|
L
 11.4%
H
2.1
2.6
|
L
 -11.7%
H
2.0
3
|
L
 -20.1%
H
2.0
3.2
|
L
 -6%
H
2.0
6.8
|
L
 -99.2%
H
0.1
364
|
L
 -100.0%
H
0.1
41100
|
L
 -100.0%
H
0.1
12024000
|
| Beauty Health Co (Class A) |
|
75.2
|
0.6
|
L
 -36.3%
H
0.6
0.8
|
L
 -31.8%
H
0.6
1.0
|
L
 -34.1%
H
0.6
1
|
L
 -54.7%
H
0.6
1.4
|
L
 -59.2%
H
0.6
2.7
|
L
 -94.5%
H
0.6
11.2
|
L
 -95.5%
H
0.6
30.2
|
L
H
0.6
30.2
|
| Sanara MedTech Inc |
|
168.6
|
18.4
|
L
 -3.6%
H
18.1
19.2
|
L
 -3.1%
H
18.1
20.1
|
L
 9.3%
H
16.2
21.5
|
L
 -9.1%
H
16.1
21.5
|
L
 -42.2%
H
16.1
36.0
|
L
 -51.3%
H
16.1
46.4
|
L
 -30.9%
H
16.1
50.2
|
L
 205.6%
H
2
75
|
| Sensus Healthcare Inc |
|
50.7
|
3.1
|
L
 -25.1%
H
2.8
3.3
|
L
 -22.4%
H
2.8
4.3
|
L
 -29.7%
H
2.8
4.6
|
L
 -38.9%
H
2.8
5.0
|
L
 -27.0%
H
2.8
5.9
|
L
 8.5%
H
1.8
9.3
|
L
 -9.4%
H
1.8
15.3
|
L
H
1.8
15.3
|
| Staar Surgical Co. |
|
1,328.8
|
26.7
|
L
 -2.2%
H
26.4
27.5
|
L
 1.3%
H
26.1
28.2
|
L
 26.6%
H
20.8
28.2
|
L
 51.8%
H
15.6
28.2
|
L
 37.3%
H
15.6
30.8
|
L
 -60.4%
H
13.5
68.3
|
L
 -80.6%
H
13.5
163.1
|
L
 264.6%
H
5.0
163.1
|
| Neuronetics Inc |
|
115.5
|
1.7
|
L
 -9.8%
H
1.6
1.8
|
L
 -14.4%
H
1.6
2.5
|
L
 5.1%
H
1.3
2.5
|
L
 6.4%
H
0.8
2.5
|
L
 -63.6%
H
0.8
4.9
|
L
 -26.9%
H
0.5
5.9
|
L
 -88.0%
H
0.5
17.9
|
L
H
0.5
39.4
|
| Star Equity Holdings Inc |
|
30.5
|
9.5
|
L
 2.3%
H
9.2
9.5
|
L
 -2.5%
H
9.2
10
|
L
 -0.7%
H
9.1
10.3
|
L
 -4.7%
H
9.0
11
|
L
 307.8%
H
1.8
12.0
|
L
 117.5%
H
1.7
12.0
|
L
 -33.6%
H
1.7
23.4
|
L
 -96.4%
H
1.7
307.5
|
| Sharps Tech Inc |
|
77.3
|
2
|
L
 7.0%
H
1.9
2.0
|
L
 12.4%
H
1.8
2.0
|
L
 28.2%
H
1.6
2.0
|
L
 21.2%
H
1.4
2.1
|
L
 -57.1%
H
1.4
18.2
|
L
 -100.0%
H
0.0
10428
|
L
H
0.0
23892
|
L
H
0.0
23892
|
| Tactile Systems Tech Inc |
|
578.6
|
25.7
|
L
 -1.4%
H
25.5
26.3
|
L
 11.4%
H
20.5
27.6
|
L
 6.7%
H
20.5
27.6
|
L
 -8.1%
H
20.5
37.8
|
L
 166.1%
H
9.3
37.8
|
L
 37.7%
H
8.6
37.8
|
L
 -54.1%
H
6.3
57.6
|
L
H
6.3
76.6
|
| TELA Bio Inc |
|
45.7
|
1.0
|
L
 -7.3%
H
1.0
1.2
|
L
 15.9%
H
0.8
1.3
|
L
 47.8%
H
0.6
1.3
|
L
 25.9%
H
0.5
1.3
|
L
 7.4%
H
0.5
2.2
|
L
 -89.5%
H
0.5
11.3
|
L
 -92.1%
H
0.5
16.5
|
L
H
0.5
23.5
|
| Valion Bio Inc |
|
3.0
|
1.0
|
L
 -7.7%
H
0.9
1.0
|
L
 -2.0%
H
0.9
1.1
|
L
 -4%
H
0.9
1.4
|
L
 11.6%
H
0.7
1.4
|
L
 -77.7%
H
0.7
5.6
|
L
 -99.6%
H
0.7
404.4
|
L
H
0.7
11050
|
L
H
0.7
11050
|
| Treace Medical Concepts Inc |
|
130.2
|
2.0
|
L
 4.7%
H
1.9
2.2
|
L
 11.1%
H
1.7
2.2
|
L
 50%
H
1.3
2.3
|
L
 -11.1%
H
1.2
2.3
|
L
 -72.1%
H
1.2
7.8
|
L
 -92.4%
H
1.2
27.7
|
L
 -93.8%
H
1.2
37.2
|
L
H
1.2
37.2
|
| Transmedics Grp Inc |
|
2,344.6
|
67.8
|
L
 -6.9%
H
67.7
72.7
|
L
 -32.7%
H
67.7
101.7
|
L
 -36.8%
H
67.7
120.9
|
L
 -49.8%
H
67.7
151
|
L
 -29.2%
H
67.7
156
|
L
 -8.3%
H
36.4
177.4
|
L
 179.9%
H
10
177.4
|
L
H
10
177.4
|
| Tandem Diabetes Care Inc |
|
1,060.4
|
15.5
|
L
 -16.2%
H
15.4
20.0
|
L
 -20.7%
H
15.4
20.4
|
L
 -15.3%
H
15.4
22.0
|
L
 -19.3%
H
15.4
29.7
|
L
 -30.5%
H
10.0
29.7
|
L
 -55.8%
H
10.0
53.7
|
L
 -81.6%
H
10.0
155.9
|
L
 -79.2%
H
2.1
155.9
|
| Trinity Biotech PLC (ADR) |
|
12.4
|
0.6
|
L
 3.4%
H
0.6
0.6
|
L
 1.7%
H
0.6
0.6
|
L
 1.7%
H
0.6
0.8
|
L
 -23.8%
H
0.5
1.0
|
L
 -96.8%
H
0.5
86
|
L
 -99.9%
H
0.5
687.5
|
L
 -100.0%
H
0.5
2487.5
|
L
 -100.0%
H
0.5
8550
|
| Utah Medical Products Inc |
|
208.1
|
65.4
|
L
 -0.1%
H
64.7
66.0
|
L
 -0.1%
H
64.2
66.0
|
L
 3.0%
H
63.4
71.8
|
L
 6.0%
H
60.9
71.8
|
L
 21.2%
H
52
71.8
|
L
 -30.2%
H
51.3
100.6
|
L
 -26.8%
H
51.3
133.9
|
L
 0.1%
H
51.3
133.9
|
| Vivani Medical Inc |
|
102.6
|
1.2
|
L
 -1.7%
H
1.2
1.2
|
L
 -11.2%
H
1.2
1.4
|
L
 12.3%
H
1.0
1.5
|
L
 -5.6%
H
0.9
1.5
|
L
 16.7%
H
0.9
1.9
|
L
 -10.5%
H
0.8
7.8
|
L
 -92.9%
H
0.8
22.9
|
L
 -98.8%
H
0.8
121.2
|
| Veracyte Inc |
|
3,214.9
|
40.4
|
L
 -0.8%
H
38.7
41.0
|
L
 22.8%
H
32.1
42.1
|
L
 25.7%
H
30.6
42.1
|
L
 11.7%
H
29.5
42.1
|
L
 31.1%
H
22.6
50.7
|
L
 73.6%
H
18.6
50.7
|
L
 -8.9%
H
14.9
54.1
|
L
 655.5%
H
4.8
86.0
|
| Varex Imaging Corp |
|
412.1
|
9.8
|
L
 -16.9%
H
9.1
11.4
|
L
 -15.6%
H
9.1
12.4
|
L
 -7.2%
H
9.1
12.8
|
L
 -29.8%
H
9.1
14.5
|
L
 20.3%
H
6.8
14.6
|
L
 -55.3%
H
6.8
23.9
|
L
 -59.9%
H
6.8
32.7
|
L
H
6.8
43.8
|
| Vivos Therapeutics Inc |
|
9.0
|
0.7
|
L
H
0.7
0.7
|
L
 -17.5%
H
0.7
0.9
|
L
 -46.8%
H
0.7
1.5
|
L
 -57.4%
H
0.7
1.9
|
L
 -75.8%
H
0.7
8.0
|
L
 -91.9%
H
0.7
48.8
|
L
 -99.6%
H
0.7
177.3
|
L
H
0.7
360.3
|
| Wrap Tech Inc |
|
82.7
|
1.5
|
L
 3.5%
H
1.4
1.5
|
L
 -3.3%
H
1.4
1.6
|
L
 0.7%
H
1.4
1.6
|
L
 -20.3%
H
1.4
1.9
|
L
 3.5%
H
1.2
3.2
|
L
 24.2%
H
1.0
7.0
|
L
 -75.2%
H
1.0
9.8
|
L
H
1.0
14.4
|
| Beyond Air Inc |
|
5.4
|
0.5
|
L
 2%
H
0.5
0.5
|
L
 -1.9%
H
0.5
0.6
|
L
 -28.2%
H
0.4
0.8
|
L
 -55.7%
H
0.4
1.3
|
L
 -85.8%
H
0.4
5.8
|
L
 -99.6%
H
0.4
127.2
|
L
 -99.5%
H
0.4
328.2
|
L
H
0.4
900
|
| DENTSPLY Sirona Inc |
|
2,203.6
|
11
|
L
 0.4%
H
10.7
11.2
|
L
 -6.4%
H
10.7
11.9
|
L
 -4.5%
H
10.7
13.0
|
L
 -20.1%
H
10.7
14.8
|
L
 -19.6%
H
9.9
17.2
|
L
 -73.4%
H
9.9
41.6
|
L
 -83.9%
H
9.9
69.5
|
L
 -82.2%
H
9.9
69.5
|
| X.T.L. Biopharma Ltd (ADR) |
|
6.0
|
2.5
|
L
 -4.9%
H
2.5
2.7
|
L
 -34.9%
H
2.5
4.0
|
L
 6.7%
H
2.3
4.9
|
L
 -40.7%
H
2.2
4.9
|
L
 -88.3%
H
2.1
41.1
|
L
 -86.7%
H
2.1
79.8
|
L
 -95.3%
H
2.1
107.0
|
L
 -97.0%
H
2.1
125.6
|
| 111 Inc (ADR) |
|
53.2
|
6.1
|
L
 8.4%
H
5.6
6.1
|
L
 -2.4%
H
5.3
6.5
|
L
 -2.7%
H
5.3
7.3
|
L
 -18.2%
H
5.3
8.5
|
L
 -19.1%
H
2.5
11.2
|
L
 120.8%
H
0.4
11.3
|
L
 -47.2%
H
0.4
12
|
L
H
0.4
45.9
|
| Jin Medical Intl Ltd |
|
16.6
|
2.1
|
L
 -3.6%
H
2.1
2.2
|
L
 0.5%
H
2
2.7
|
L
 5.5%
H
1.9
2.7
|
L
 -23.7%
H
1.6
3.2
|
L
 -86.9%
H
1.6
18
|
L
 -62.8%
H
1.6
509.9
|
L
H
1.6
509.9
|
L
H
1.6
509.9
|
| HeartBeam Inc |
|
47.7
|
0.9
|
L
 2.3%
H
0.9
0.9
|
L
 3.5%
H
0.8
0.9
|
L
 -23.9%
H
0.8
1.3
|
L
 -37.8%
H
0.8
1.8
|
L
 -52.7%
H
0.5
4
|
L
 -43.7%
H
0.5
4
|
L
 -43.7%
H
0.5
4
|
L
 -43.7%
H
0.5
4
|
| Cencora |
|
50,791.8
|
261.1
|
L
 2.1%
H
254
266.4
|
L
 -15.2%
H
244.8
310.4
|
L
 -18.6%
H
244.8
328.0
|
L
 -27.3%
H
244.8
376.9
|
L
 -14.3%
H
244.8
377.5
|
L
 55.4%
H
163.4
377.5
|
L
 116.0%
H
111.3
377.5
|
L
 241.2%
H
68.4
377.5
|
| Incannex Healthcare Ltd (ADR) |
|
64.0
|
4.6
|
L
 -4.6%
H
4.6
5.0
|
L
 4.3%
H
4.4
5
|
L
 69%
H
2.7
5
|
L
 -47.0%
H
2.5
9.3
|
L
 26.2%
H
2.4
49.8
|
L
 -97.2%
H
2.4
160.2
|
L
 -97.2%
H
2.4
160.2
|
L
 -97.2%
H
2.4
160.2
|
| Rewalk Robotics Ltd |
|
17.5
|
6.3
|
L
 -6.8%
H
6.3
6.7
|
L
 -13.5%
H
6.3
7.5
|
L
 -4.3%
H
6.1
7.7
|
L
 -7.9%
H
4.1
7.7
|
L
 -61.1%
H
4.1
17.8
|
L
 -87.7%
H
4.1
109.2
|
L
 -95.6%
H
4.1
233.5
|
L
 -100.0%
H
4.1
20790
|
| Work Medical Tech Grp Ltd |
|
1.6
|
1.3
|
L
 -2.3%
H
1.3
1.3
|
L
 5.8%
H
1.2
1.4
|
L
 10.3%
H
1.1
1.4
|
L
 -7.3%
H
1.1
1.8
|
L
 -100.0%
H
1.1
10800
|
L
H
1.1
84460
|
L
H
1.1
84460
|
L
H
1.1
84460
|
| iTonic Holdings Ordinary |
|
5.5
|
0.3
|
L
 -5.9%
H
0.3
0.3
|
L
 -11.1%
H
0.3
0.4
|
L
 3.2%
H
0.3
0.4
|
L
 -18.0%
H
0.3
0.5
|
L
 -92.8%
H
0.3
32
|
L
H
0.3
32
|
L
H
0.3
32
|
L
H
0.3
32
|
| Ceribell Inc |
|
765.0
|
20.2
|
L
 -0.9%
H
19.8
20.6
|
L
 0.2%
H
19.7
20.9
|
L
 13.0%
H
17.8
21.7
|
L
 0.3%
H
16.8
22.0
|
L
 26.2%
H
10.9
24.3
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
| Anteris Tech Global Corp |
|
639.8
|
6.6
|
L
 1.1%
H
6.3
6.6
|
L
 7.0%
H
5.9
6.6
|
L
 23.7%
H
5.3
6.6
|
L
 19.9%
H
5.0
7.0
|
L
 63.3%
H
2.9
7.0
|
L
H
2.3
8.8
|
L
H
2.3
8.8
|
L
H
2.3
8.8
|
| Beta Bionics Inc |
|
430.0
|
9.7
|
L
 -8.1%
H
9.6
10.5
|
L
 -5.4%
H
9.6
11.0
|
L
 -0.8%
H
8.8
13.4
|
L
 -26.2%
H
8.8
15.5
|
L
 -32.9%
H
8.8
32.7
|
L
H
8.8
32.7
|
L
H
8.8
32.7
|
L
H
8.8
32.7
|
| Wellgistics Health Inc |
|
10.1
|
0.1
|
L
 -11.1%
H
0.1
0.1
|
L
 -27.3%
H
0.1
0.1
|
L
 -38.5%
H
0.1
0.2
|
L
 -74.2%
H
0.1
0.3
|
L
 -98.2%
H
0.1
7.0
|
L
H
0.1
7.0
|
L
H
0.1
7.0
|
L
H
0.1
7.0
|
| Kestra Medical Tech Ltd |
|
1,228.8
|
21.1
|
L
 -2.2%
H
21.0
21.6
|
L
 1.6%
H
19
22.4
|
L
 8%
H
17.3
24.5
|
L
 -17.4%
H
17.3
28.2
|
L
 -3.6%
H
13.3
30
|
L
H
13.3
30
|
L
H
13.3
30
|
L
H
13.3
30
|
| Sanuwave Health Inc |
|
133.9
|
15.6
|
L
 -6.5%
H
15.4
16.4
|
L
 -4.9%
H
15.4
17.1
|
L
 -5.9%
H
15.4
21.2
|
L
 -39.7%
H
15.4
26.6
|
L
 -51.8%
H
15.4
46.6
|
L
 -51.8%
H
15.4
46.6
|
L
 -51.8%
H
15.4
46.6
|
L
 -51.8%
H
15.4
46.6
|
| SS Innovations Intl Inc |
|
774.5
|
3.9
|
L
 -1.5%
H
3.8
4.0
|
L
 -3.7%
H
3.7
4.2
|
L
 -19.0%
H
3.7
5.1
|
L
 2.1%
H
3.3
5.3
|
L
 -61.9%
H
3.0
11.9
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
| Medline Inc Ordinary Shares |
|
32,370.1
|
39.5
|
L
 -5.6%
H
39.1
42.2
|
L
 -11.1%
H
39.1
45.7
|
L
 -8.4%
H
39.1
49.1
|
L
 -16.5%
H
39.1
50.9
|
L
 -3.6%
H
38
50.9
|
L
 -3.6%
H
38
50.9
|
L
 -3.6%
H
38
50.9
|
L
 -3.6%
H
38
50.9
|